Its formulation is based on the original MIC (Methionine, Inositol and Choline) lipotropic base but additionally includes additional B-complex vitamins, namely B6 and B12 and several chosen amino acids making it a more potent metabolic support medication than standard MIC and the simple B12 injection alone
One clinical trial has tested the safety and efficacy of CB4211, a MOTS-c analogue, in the treatment of obese subjects with nonalcoholic fatty liver disease, where it was found to be effective at reducing body weight and liver fat content
Daily intraperitoneal injections of AOD9604 or hGH were then administered for 28 days, during which time body weight and food intake were recorded every other day
These characteristics make it a frequent focus in recovery-oriented research protocols
Average Cost : $20 to $50 per injection
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
